ERG245

SKU: orb2663576

Description

ERG245 is a selective BCAT1 inhibitor that enhances CD8+ T cell cytotoxicity by promoting oxidative phosphorylation. In preclinical immuno-oncology research, it has demonstrated synergistic antitumor activity with anti-PD-1 therapy, such as pembrolizumab, in both in vitro and in vivo models.

Key Properties

• MW: 347.2
• Formula: C₁₇H₁₅BrO₃
• SMILES: BrC1=CC=C(C(C(C2=CC=CC=C2)CCC(O)=O)=O)C=C1
• Target: Others

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

Others